DGAPNews MorphoSys AG Key words Study19.11.2018 2201 The issuer is solely responsible for the content of this announcement.PlaneggMunich Germany November 19 2018 MorphoSys Announces Its Licensee Janssen Initiated a Phase 2 Study NOVA to Evaluate Guselkum...
↧